Yili Kevin Xie - Net Worth and Insider Trading

Yili Kevin Xie Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Yili Kevin Xie owns 4 companies in total, including Alpha Healthcare Acquisition Corp (AHACU) , ViewRay Inc (VRAYQ) , and Humanigen Inc (HGENQ) among others .

Click here to see the complete history of Yili Kevin Xie’s form 4 insider trades.

Insider Ownership Summary of Yili Kevin Xie

Ticker	Comapny	Transaction Date	Type of Owner
AHACU	Alpha Healthcare Acquisition Corp	2020-09-17	director
VRAYQ	ViewRay Inc	2019-10-24	director
HGENQ	Humanigen Inc	2021-10-19	director
		2020-09-17	director

Yili Kevin Xie Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Yili Kevin Xie Ownership Network

Ownership Network List of Yili Kevin Xie

No Data

Ownership Network Relation of Yili Kevin Xie

Yili Kevin Xie Owned Company Details

What does Alpha Healthcare Acquisition Corp do?

Who are the key executives at Alpha Healthcare Acquisition Corp?

Yili Kevin Xie is the director of Alpha Healthcare Acquisition Corp. Other key executives at Alpha Healthcare Acquisition Corp include and director & 10 percent owner & Chief Executive Officer Rajiv Shukla .

Alpha Healthcare Acquisition Corp (AHACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alpha Healthcare Acquisition Corp (AHACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alpha Healthcare Acquisition Corp (AHACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alpha Healthcare Acquisition Corp (AHACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alpha Healthcare Acquisition Corp Insider Transactions

No Available Data

What does ViewRay Inc do?

Who are the key executives at ViewRay Inc?

Yili Kevin Xie is the director of ViewRay Inc. Other key executives at ViewRay Inc include SVP & General Counsel Sanket Shah , 10 percent owner Farhad Fred Ebrahimi , and Chief Commercial Officer Paul Jr Ziegler .

ViewRay Inc (VRAYQ) Insider Trades Summary

Over the past 18 months, Yili Kevin Xie made no insider transaction in ViewRay Inc (VRAYQ). Other recent insider transactions involving ViewRay Inc (VRAYQ) include a net sale of 110,324 shares made by B Kristine Johnson , a net sale of 8,203,610 shares made by Farhad Fred Ebrahimi , and a net sale of 2,408,747 shares made by Scott William Drake .

In summary, during the past 3 months, insiders sold 0 shares of ViewRay Inc (VRAYQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,529,227 shares of ViewRay Inc (VRAYQ) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 13,504,227 shares.

ViewRay Inc (VRAYQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

ViewRay Inc Insider Transactions

No Available Data

What does Humanigen Inc do?

Who are the key executives at Humanigen Inc?

Yili Kevin Xie is the director of Humanigen Inc. Other key executives at Humanigen Inc include 10 percent owner Dale Chappell , Chief Medical Officer Adrian Kilcoyne , and Chief Commercial Officer Edward P. Jordan .

Humanigen Inc (HGENQ) Insider Trades Summary

Over the past 18 months, Yili Kevin Xie made no insider transaction in Humanigen Inc (HGENQ). Other recent insider transactions involving Humanigen Inc (HGENQ) include a net sale of 386,350 shares made by Dale Chappell ,

In summary, during the past 3 months, insiders sold 0 shares of Humanigen Inc (HGENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 386,350 shares of Humanigen Inc (HGENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 386,350 shares.

Humanigen Inc (HGENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Humanigen Inc Insider Transactions

No Available Data

What does Humacyte Inc do?

Who are the key executives at Humacyte Inc?

Yili Kevin Xie is the director of Humacyte Inc. Other key executives at Humacyte Inc include director & 10 percent owner Brady W Dougan , director & 10 percent owner & President & CEO and Director Laura E Niklason , and 10 percent owner Ayabudge Llc .

Humacyte Inc (HUMA) Insider Trades Summary

Over the past 18 months, Yili Kevin Xie made no insider transaction in Humacyte Inc (HUMA). Other recent insider transactions involving Humacyte Inc (HUMA) include a net sale of 12,728,864 shares made by Brady W Dougan , a net sale of 7,853,864 shares made by Laura E Niklason , and a net sale of 10,738,864 shares made by Ayabudge Llc .

In summary, during the past 3 months, insiders sold 0 shares of Humacyte Inc (HUMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 31,364,994 shares of Humacyte Inc (HUMA) were sold and 49,750 shares were bought by its insiders, resulting in a net sale of 31,315,244 shares.

Humacyte Inc (HUMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Humacyte Inc Insider Transactions

No Available Data

Yili Kevin Xie Mailing Address

Above is the net worth, insider trading, and ownership report for Yili Kevin Xie. You might contact Yili Kevin Xie via mailing address: C/o Viewray, Inc., 2 Thermo Fisher Way, Oakwood Village Oh 44146.

Discussions on Yili Kevin Xie

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.